Vascular wound closure device

CA 02801969 2013-01-10

VASCULAR WOUND CLOSURE DEVICE

Background of the Invention

Field of the Invention

The present invention generally relates to a system that facilitates closure of openings in blood vessels. More specifically, the present invention delivers a material adjacent a vessel.

Description of the Related Art

In many medical procedures, it is necessary to locate an opening in tissue so that some form of treatment, diagnosis or revision, can be applied to that opening. For example, in order to perform transluminal balloon angioplasty, an opening must be created in an artery in order to insert a balloon. This opening must later be closed.

Transluminal balloon angioplasty is used in the treatment of peripheral vascular disease to increase or restore blood flow through a significantly narrowed artery in a limb; it is also used in the treatment of blockage of the coronary arteries. In fact, coronary angioplasty has emerged as a major viable alternative to bypass surgery for revascularization of stenotic and occluded coronary arteries. Unlike bypass surgery, angioplasty does not require general anesthesia, opening of the chest wall, use of a heartlung machine, or transfusion of blood. Angioplasty is not only less invasive and less traumatic to the patient, but is also less expensive because of the shorter hospital stay and shorter recovery time.

Transluminal balloon angioplasty is performed by first inserting a hollow needle through the skin and surrounding tissues and into the patient's femoral artery. A guidewire is advanced through the hollow needle and into the artery, then along the patient's vasculature toward the site of the blocked blood vessel or valve to be treated. X-ray imaging is used to help guide the guidewire through the vascular system and into position

-1CA 02801969 2013-01-10 adjacent the stenosis to he treated. A balloon catheter is then threaded over the guidewire and advanced until the deflated balloon is within the stenosis, The balloon is then repeatedly inflated to widen the narrowed blood vessel. After the procedure is complete, the catheter and guidewire are withdrawn from the blood vessels and the patient.

After the catheter used during angioplasty is removed, the puncture wound in the femoral artery must be closed and the bleeding through the puncture site in the artery stopped. Often, ice packs and/or pressure are applied to the area surrounding the wound for a period lasting up to several hours in an attempt to stop the bleeding. There exists, however, a significant chance that the wound will reopen and begin bleeding again when the patient moves. Another possible complication is the development of a false aneurysm, which increases the risks of both infection and reopening.

Efforts have been made to close the puncture wound using staples, clips, collagen plugs, and sutures. These efforts, and the devices incident thereto, tend to be cumbersome and achieve only limited success.

Other wounds in the vasculature of a patient can also be difficult to locate, access and close. Thus, a device and method to facilitate locating and closing such wounds in the vasculature of a patient would be beneficial. A device having the ability to consistently and reliably locate, isolate and close the puncture wound would eliminate the prolonged bleeding currently associated with such wounds.

Summary of the Invention

Accordingly, there is a need in the art for a device and method for precisely locating a blood vessel wound and sealing the wound.

In accordance with one embodiment, an apparatus is provided for subcutaneously delivering a material. The apparatus comprises an elongate delivery tube having a chamber configured to accommodate a material therewithin, an elongate pusher member having a distal portion configured to slidably extend through at least a portion of the delivery tube so as to push at least a portion of the material out of the delivery tube, and a flexible locking member configured to fit at least partially around the pusher member and adapted to expand in a transverse direction when subjected to generally longitudinal compression. The flexible locking member is disposed adjacent the pusher member so that when the locking member is subjected to generally longitudinal compression, the locking member expands

-2CA 02801969 2014-05-26 transversely to engage the pusher member to increase friction between the pusher member and the locking member.

hi accordance with another embodiment, the pusher member has at least one protuberance. The flexible locking member is disposed adjacent the protuberance so that when the locking member is subjected to longitudinal compression, the locking member expands transversely to engage the pusher member protuberance so that the pusher member is restrained from moving relative to the locking member.

In accordance with yet another embodiment, the present invention describes an assembly for closing a vascular wound. The assembly includes a delivery tube configured to accommodate a hemostatic material therewithal, an apparatus configured to position a distal end of the delivery tube adjacent the vascular wound, a pusher member having a distal portion configured to fit at least partially through the proximal end of the delivery tube, and an adjustable stoppa: disposed about a surface of the pusher member. A portion of the pusher member has a diameter larger than the diameter of at least a portion of the delivery tube. The adjustable stopper is configured to engage the surface of the pusher member and to selectively move proximally or distally along the surface of. the pusher member to adjustably couple the apparatus and the delivery tube.

For purposes of summarizing the preferred embodiments and the advantages achieved over the prior art, certain embodiments and advantages have been described herein above. Of course, it is to be understood that not necessarily all such advantages may be achieved in accordance with any particular embodiment Thus, for example, those skilled in the art will recognize that the invention may be embodied or carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other objects or advantages as may be taught or suggested herein.

-3CA 02801969 2014-05-26

In selected embodiments, the invention provides an apparatus for subcutaneously delivering a material. The apparatus may include an elongate catheter, an elongate pusher member, and a flexible locking member. The elongate delivery tube may have a chamber configured to accommodate a malleable material therewithin. The elongate catheter may extend longitudinally through the delivery tube, the chamber being defined between the catheter and the delivery tube. The elongate pusher member may have a distal portion configured to slidably extend through at least a portion of the delivery tube chamber so as to push at least a portion of the material out of the delivery tube, the pusher member having a surface with at least one protuberance disposed proximal a distal end of the pusher member and distal a proximal end of the pusher member so that the surface extends both proximally and distally of the protuberance, the pusher member protuberance having a protuberance length along the elongate pusher member; and, a flexible locking member configured to fit at least partially around the pusher member and adapted to expand in a transverse direction when subjected to generally longitudinal compression, the flexible locking member having a longitudinal length that is greater than the protuberance length. The flexible locking member may be disposed adjacent the pusher member protuberance so that when the locking member is subjected to generally longitudinal compression, the locking member expands transversely to simultaneously engage the pusher member protuberance and the pusher member surface adjacent the protuberance to increase friction between the pusher member and the locking member so that the pusher member is restrained from moving relative to the locking member.

In an alternative embodiment, the invention provides an apparatus for subcutaneously delivering a material, the apparatus including an elongate delivery tube, an elongate catheter, an elongate pusher member, and a flexible locking member. The elongate delivery tube may have a chamber enclosing a malleable fibrous hemostatic material therewithin, a distal portion of the delivery tube having a smaller diameter than a proximal portion of the delivery tube. The elongate catheter may extend through the delivery tube, the chamber being defined as space between the catheter and the delivery tube, the distal portion of the delivery tube engaging the catheter. The elongate pusher member may have a surface with at least one protuberance, and additionally comprising a distal portion configured to slidably extend through at least a portion of the delivery tube so as to push at least a portion of the material

- 3a CA 02801969 2014-05-26 out of the delivery tube, a portion of the pusher member having a diameter less than the proximal portion of the delivery tube but greater than the distal portion of the delivery tube so that when the pusher is moved distally relative to the delivery tube, the pusher member portion engages an inner surface of the distal portion of the delivery tube and deforms the delivery tube, the pusher member portion being disposed within the delivery tube chamber proximal of the hemostatic material so that the hemostatic material is enclosed between the pusher member portion, delivery tube and catheter. The flexible locking member may be configured to fit at least partially around the pusher member portion and adapted to expand in a transverse direction when subjected to generally longitudinal compression; wherein the flexible locking member is disposed adjacent the protuberance on the pusher member portion so that when the locking member is subjected to generally longitudinal compression, the locking member expands transversely to engage the pusher member protuberance and the pusher member surface adjacent the protuberance so as to increase friction between the pusher member and the locking member so that the pusher member is restrained from moving relative to the locking member, and wherein the locking member simultaneously engages the pusher member and the delivery tube.

In another embodiment, the invention provides an apparatus for subcutaneously delivering a material, comprising: an elongate delivery tube comprising first and second elongate tube members configured to move between an engaged closed position and an open position, the tube members forming the delivery tube when in the engaged closed position, the delivery tube having a chamber configured to accommodate a material therewithin; an elongate pusher member having a distal portion configured to slidably extend through at least a portion of the delivery tube chamber so as to push at least a portion of the material out of the delivery tube chamber; a flexible collar disposed about the tube members, the collar being biased to exert an inwardly-directed force on the delivery tube to hold the tube members in the closed position; wherein the delivery tube generally tapers along its length, and as the delivery tube tapers in a proximal direction a diameter of the chamber increases; wherein the distal portion of the elongate pusher member is configured to fit in a proximal portion of the delivery tube chamber; and wherein a diameter of the distal portion of the pusher member is greater than a diameter of a distal portion of the chamber near a distal end of the delivery tube.

-3bCA 02801969 2014-05-26

In another embodiment, the invention provides an apparatus for use in closing a subcutaneous wound, comprising: an elongate delivery tube comprising first and second elongate tube members configured to move between an engaged closed position and an open position, the tube members forming the delivery tube when in the engaged closed position, the delivery tube having a chamber configured to accommodate a material therewithin, the chamber tapering along its length so that a diameter of the chamber increases moving proximally from a distal end of the chamber, the chamber having a proximal portion and a distal portion; a flexible collar disposed about the tube members, the collar being biased to exert an inwardly-directed force on the delivery tube to hold the tube members in the closed position;

an elongate pusher having a distal portion configured to fit in the proximal portion of the chamber when the delivery tube is closed, the pusher distal portion having a diameter greater than a diameter of the distal portion of the chamber; a distal tip of the delivery tube configured to be arranged at or adjacent a subcutaneous wound; wherein the elongate pusher is configured to be movable distally relative to the delivery tube so that the distal portion of the pusher engages the first and second elongate tube members and forces the first and second elongate tube members apart and into an open position and also pushes material within the chamber distally out of the chamber.

The embodiments discussed above and other embodiments will become readily apparent to those skilled in the art from the following detailed description of the preferred embodiments having reference to the attached figures, the invention not being limited to any particular preferred embodiment(s) disclosed.

Brief Description of the Drawings

Figure 1 is a side view of an embodiment of a vascular closure apparatus shown assembled and ready for use.

- 3c CA 02801969 2013-01-10

Figure 2 is a side view of a distal portion of the apparatus of Figure 1.

Figure 3 is a side view of a push member having features in accordance with the present invention.

Figure 4 shows the apparatus of Figure 1 advanced over a guidewire into a blood vessel of a patient.

Figure 5 shows the arrangement of Figure 4 with the retractor arms open and a suction tool in use.

Figure 6 shows the arrangement of Figure 5, wherein a hemostatic sponge has been advanced into contact with the blood vessel wall.

Figure 7 shows the arrangement of Figure 6, with the retractor arms removed.

Figure 8 shows the arrangement of Figure 7 with the catheter and guidewire removed.

Figure 9 shows the arrangement of Figure 8, wherein a flowable adhesive is being delivered to the sponge.

Figure 10 shows the arrangement of Figure 8, wherein the push member is being removed from the patient.

Figure 11' shows a sealed puncture wound after treatment with an embodiment of the device and method.

Figure 12 shows another embodiment of a vascular wound closure apparatus.

Figure 13 shows a side view of a catheter for use according to the embodiment illustrated in Figure 12.

Figure 14 shows a retractor portion of the apparatus of Figure 12 with the retractor aims in an open position.

Figure 15 shows a side plan view of one of the retractor aims illustrated in 25 Figure 14.

Figure 16 shows the catheter of Figure 13 disposed in the retractor aim of Figure 15.

Figure 17 shows a partially cutaway view of another embodiment of a vascular wound closure apparatus.

Figure 18 shows a side view of a catheter according to the embodiment illustrated in Figure 17.

-4CA 02801969 2013-01-10

Figure 19 shows a partially cutaway view of a pusher member according to the embodiment illustrated in Figure 17.

Figure 20 shows a partially cutaway view of a delivery tube according to the embodiment illustrated in Figure 17.

Figure 21 shows a cross section of the delivery tube of Figure 20 taken along line

21-21.

Figure 22 shows a wall portion of the delivery tube of Figure 20 having a detent catch coupling portion.

Figure 23 shows the apparatus of Figure 12 during use.

Figure 24 shows a wall portion of another embodiment of a delivery tube having a j-lock coupling portion.

Figure 25 shows another embodiment of a vascular wound closure apparatus.

Figure 26 shows a partially cutaway side view of a catheter according to the embodiment illustrated in Figure 25.

Figure 27 shows a partially cutaway cross-sectional view of a pusher member according to the embodiment illustrated in Figure 25.

Figure 28 shows a partially cutaway view of a delivery tube according to the embodiment illustrated in Figure 25.

Figure 29 shows another embodiment of a vascular wound closure apparatus.

Figure 30 shows a partially cutaway side view of a catheter according to die embodiment illustrated in Figure 29.

Figure 31 shows a partially cutaway cross-sectional view of a pusher member according to the embodiment illustrated in Figure 29.

Figure 32 a shows a side view of a handle support for use in connection with the 25 pusher member of Figure 31.

Figure 32b shows atop view of the handle support of Figure 32a.

Figure 33 shows a top view of the handle for use in connection with the pusher member of Figure 31.

Figure 34 shows a top view of the coupling member for use in connection with the 30 pusher member of Figure 31.

Figure 35 shows a partially cutaway view of a delivery tube according to the embodiment illustrated in Figure 29.

-5CA 02801969 2013-01-10

Figure 36 shows the delivery tube of Figure 35 separated into two halves.

Figure 37 is a side view of a fully-assembled vascular wound closure device having features in accordance with the embodiment illustrated in Figure 29.

Figure 38 shows the apparatus of Figure 37 with the catheter, pusher member and delivery tube uncoupled from one another.

Figure 39 shows the apparatus of Figure 37 deploying a hemostatic agent.

Figure 40 is a side view of another embodiment of a vascular wound closure apparatus.

Figure 41 is a cross sectional view of the apparatus of Figure 40.

Figure 42a is a close up view of a portion of the apparatus of Figure 41.

Figure 42b is a close up view of another portion of the apparatus of Figure 41. Figure 43 shows a portion of the apparatus of Figure 41 in position adjacent a vascular wound.

Figure 44 shows a delivery tube portion of the apparatus of Figure 41 separated into halves.

Figure 45 shows a pusher member of the apparatus of Figure 41.

Figure 46 is a close up view showing a distal end of the pusher member of Figure fit into a proximal end of the delivery tube of Figure 44.

Figure 47 shows a catheter portion of the apparatus of Figure 41.

Figure 48 is a close up view showing the catheter of Figure 47 attached to a proximal end of the pusher member of Figure 45.

Figure 49 is a perspective view of a collar portion of the apparatus of Figure 41. Figure 50 shows a portion of the apparatus of Figure 41 being advanced toward a tissue wound.

Figure 51 shows the arrangement of Figure 50 with the apparatus in position adjacent the wound and deploying a hemostatic agent.

Detailed Description of Preferred Embodiments The present embodiments are especially useful for closing vascular puncture wounds that are difficult to access and/or visualize. It is difficult to directly and accurately modify a wound in a blood vessel in order to close such wounds. Additionally, there are pitfalls associated with directly modifying the blood vessel. For example, since the clinician cannot see the wound, it is difficult to correctly place closure media such as

-6CA 02801969 2013-01-10 sutures, staples, or clips. Incorrect placement of such closure media likely results in inadequate closure; the puncture wound remains open, perhaps without the clinician being aware. Additionally, mconect placement of closure media may cause permanent damage to the vessel, including tearing and additional puncture wounds. Further, if closure media extends through the wound and into the blood flow, this media can increase the likelihood of thrombus formation or could introduce potentially toxic substances into the bloodstream. Of course, closure media inadvertently released into the bloodstream could lead to serious blood vessel blockage complications.

With reference to Figure 1, a vascular wound closure assembly 30 includes an elongate catheter 32 having a distal end 34 and a proximal end 36 of the catheter 32. A distal opening 38 is formed through the distal end 34 of the catheter 32 and opens along a longitudinal axis of the catheter 32. The catheter 32 includes a tapered tip 40 at the distal end 34. An elongate main body 42 of the catheter 32 is disposed proximal the tapered tip 40. Preferably the main body 42 has a substantially uniform diameter along its length. A lumen 44 extends longitudinally within the catheter 32 from the distal opening 38 to the proximal end 36.

A connector portion 46 is provided on the proximal end 36. The connector portion 46 includes a main lumen 48 and a secondary lumen 50. The main lumen 48 extends along the longitudinal axis of the catheter 32 and is coextensive with the catheter lumen 44. The secondary lumen 50 extends outwardly from the main lumen 48, but communicates with the main lumen 48 and the catheter lumen 44. A proximal opening 52 is provided at the proximal end of the main lumen 48 and, like the distal opening 38, opens along the longitudinal axis. A secondary opening 54 opens into the secondary lumen 50.

The distal and proximal openings 38, 52 are sized and adapted to accommodate a guidewire 58 such as the guidewire used in angioplasty and other vascular surgeries. As such, tlie guidewire 58 can be threaded through the catheter 32 and the catheter can he advanced over the guidewire 58,

Holes 60 are formed through a side wall of the catheter 32 near the distal end 34 of the catheter 32. Preferably, at least two holes 60 are provided. All of the holes 60 preferably are disposed substantially the same distance from the distal end 34 of the catheter 32. Preferably, a raised portion 62 of the catheter 32 is provided in the region around the holes 60, which region is proximal of the tip 40 and distal of the main body 42.

-7CA 02801969 2014-05-26

At the raised portion 62, the catheter 32 has an outer diameter that is slightly larger than the outer diameter throughout the catheter main body 42.

With continued reference to Figure 1, a vacuum or other source of suction 64 is provided and communicates, through tubing 66, with the secondary lumen 50 of the catheter connector portion 46. Thus, a vacuum is drawn through the catheter lumen 44. Preferably, the distal and proximal openings 38, 52, which accommodate the guidewire 58, are sized so that the guidewire 58 substantially plugs the openings; thus, the vacuum is drawn through the holes 60. A viewing port 68 is arranged between the source of suction 64 and the catheter 32. The viewing port 68 is configured to allow a clinician to view the material that is drawn by suction through the holes 60 and through the catheter lumen 44. The viewing port 68 will be discussed in more detail below.

With reference to Figures 1 and 2, a retractor 70 preferably is mounted on the catheter 32. The retractor 70 includes opposing elongate retractor arms 72 that are aligned longitudinally on the catheter 32. A retractor body 74 is configured to selectively open and close the retractor arms 72 when operated by a clinician. The elongate retractor arms 72 of the retractor 70 are positioned on the catheter 32 so that distal ends 76 of the arms are positioned proximal of the catheter holes 60 a distance that is at least the same as the width of an artery wall, preferably at least about .5 to 2 millimeters.

It is to be understood that the present device can include structure that is somewhat different than the particular structure shown in Figures 1 and 2. For example, other catheter and retractor structures can appropriately be used. For example, some acceptable catheter and retractor embodiments are presented in U.S. Application Serial No. 09/325,982, filed on June 4, 1999, now U.S. Patent No. 6,287,322.

With reference again to Figure 1, a hemostatic member 80 is arranged on the catheter 32 proximal of the retractor 70. As will be discussed in more detail below, the hemostatic member comprises a material that is made of or includes a hemostatic agent. The hemostatic agent is adapted to aid blood clotting. In one embodiment, the hemostatic member 80 comprises a sponge or sponge-like material, hi this description, the term sponge is intended to be a broad term that is used in accordance with its ordinary meaning and refers to, without limitation, a material that is at least partially porous and is adapted to allow at least some blood to flow into and within the material so as to soak the material

-8CA 02801969 2013-01-10 with blood. For example, a sponge may include a natural or artificial sponge, a woven or non-woven cloth, a fibrous puff or the like. Additionally, a sponge may comprise a material that soaks up at least a portion of blood that may come in contact with the material, or may comprise a material that doesn't soak up blood.

For purposes of this description, the hemostatic member 80 is referred to as the sponge 80. However, it is to be understood that use of the term sponge does not limit the scope of materials that can be used as the hemostatic member, hi fact, any material that aids or facilitates blood clotting can be used as the hemostatic member.

Throughout this description, the term hemostatic agent is used as a broad term in its ordinary sense and refers to, without limitation, an agent that promotes blood clotting. Such an agent may take many forms, including liquid, powder, beads, etc. and can include or be combined with a substrate or carrier. The term hemostatic material is also used in this description as a broad term used in its ordinary sense. It refers to, without limitation, any material having properties that promote blood clotting. Thus, hemostatic material can include a hemostatic agent taken alone or in combination with a substrate or carrier that is formed separately from the agent. The term hemostatic material includes hemostatic sponges.

Preferably, the sponge 80 extends circumferentially around the catheter main body 42, and is arranged so that it can be slid longitudinally along the catheter 32. Most preferably, the catheter 32 extends through a passageway 82 through the sponge 80. The passageway 82 is formed as the catheter 32 is forced through the sponge 80.

A push member 84 is also arranged on the catheter 32 proximal of the sponge 80. With reference also to Figure 3, the push member 84 comprises a body portion 86 and a proximal handle portion 88. An elongate lumen 90 is formed through the body portion 86.

As shown in Figure 1, the lumen 90 preferably encircles the catheter 32 so as to allow the push member 84 to slide relative to the catheter 32. A plurality of holes 92 are formed through the body portion 86 at a point near the distal end of the push member 84.

As will be discussed in more detail below in connection with Figure 4, the vascular wound closure assembly 30 enables a clinician to precisely locate a subcutaneous vascular wound w, access the wound w, and deliver the hemostatic sponge 80 to the wound site. The hemostatic sponge 80 includes a hemostatic agent that helps facilitate closure of the wound w.

-9CA 02801969 2013-01-10

In order to properly apply the hemostatic sponge 80, the vascular closure assembly first precisely locates and provides access to the vascular wound w. It is to be understood that the present method and apparatus can be used to close various vascular and other wounds. Figures 1-11, and the accompanying discussion, present an example using an embodiment to close a puncture wound w in a patient's femoral artery 94.

With specific reference to Figures 1, 2, 4 and 5, in order to precisely locate and provide access to a femoral artery puncture wound w, the catheter 32 is first threaded over a guidewire 58 that has been previously inserted into the patient's femoral artery 94 through the puncture wound w. The lumen 44 is attached to the source of suction 64 and the assembly 30 is advanced over the guidewire 58 through a patient's tissue 96 so that the distal tip 40 of the catheter 32 extends through the vascular puncture wound w.

As the assembly 30 is advanced, the source of suction 64 draws bodily fluids through the holes 60. The fluids pass through the viewing port 68, which allows the clinician to identify the fluids being withdrawn. The viewing port 68 can have any suitable structure or location. For example, the viewing port can comprise clear tubing attached to the catheter, a substantially transparent syringe that functions as both a source of suction and a viewing port, or a portion of the catheter that is substantially transparent. Most preferably, the catheter 32 is formed of a transparent material so that the clinician becomes aware as soon as blood begins to be drawn through the catheter.

When the holes 60 pass the artery wall 98 and enter the blood vessel 94, as shown in Figure 4, blood b begins to be drawn through the holes 60 into the catheter 32 and is conducted past the viewing port 68. Thus, when blood b is observed in the viewing port 68, the clinician will know that the holes 60 have just passed into the puncture wound w and that the distal ends 76 of the retractor arms 72 are thus positioned adjacent the outer wall 98 of the artery 94, preferably within about 2 nun of the artery wall 98. The retractor arms 72 are then separated as shown in Figure 5, thus drawing surrounding tissue 96 away from the wound w and creating a field 100 around the puncture wound w. The catheter 32 remains disposed partially within the puncture wound w, effectively plugging the wound and preventing blood from flowing through the wound. The raised portion 62 flexes the edges of the wound w to enhance the seal between the catheter 32 and the puncture wound edges.

-10CA 02801969 2013-01-10

With continued reference to Figure 5, a suction tool 102 can be used to clear away bodily fluids and other matter that may be within the field 100 and to clean the wall 98 of the blood vessel 94 adjacent the puncture wound w.

With reference next to Figure 6, once the puncture wound w has been precisely located, the push member 84 is advanced distally along the catheter 32, thus advancing the sponge 80 into contact with the vessel wall 98 so as to surround the puncture wound w. As mentioned above and discussed in more detail below, the sponge 80 comprises a hemostatic agent that will help accelerate blood clot formation at the wound site w in order to help the wound heal faster.

Preferably, the sponge 80 is at least partially coated with an adhesive so that the sponge will at least partially bond to the vessel wall 98. Alternatively, or in addition, flowable adhesive can be delivered into the field around the puncture wound before the sponge is advanced into contact with the vessel wall. Of course, tire sponge can be delivered without using any adhesive.

The sponge 80 preferably is mounted onto the catheter 32 so as to substantially encircle the catheter 32. Thus, since the tip 40 of the catheter is disposed in the wound, the sponge 80 substantially surrounds the wound w when the sponge is positioned adjacent the vessel wall 98. When the sponge 80 is in place adjacent the wound w, the retractor 70 can be removed, as shown in Figure 7. When the retractor 70 is removed, the surrounding body tissues 96 collapse around the sponge 80 and push member 84. The push member 84 holds the sponge 80 in position while body tissue 96 surrounds the sponge 80 and while the adhesive cures.

With reference next to Figure 8, with the push member 84 in place, the catheter 32 and guidewire 58 can also be removed from the patient. The passage 82 through the sponge 80, which had been occupied by the catheter 32, collapses onto itself so that it is substantially closed. Tire vessel wound w is no longer plugged by the catheter 32, and it is anticipated that blood b from the vessel 94 will flow into the sponge 80, at least partially soaking the sponge 80. Although the retractor 70 is removed prior to the catheter 32 in the above-discussed embodiment, it is to be understood that, in another embodiment, tire catheter may be removed prior to the retractor.

In still another embodiment, additional pressure can be applied to the push member 84 in order to at least partially block blood flow through the blood vessel 94. hr this

-11CA 02801969 2013-01-10 manner, the clinician can control how quickly blood will flow through the wound w and into the sponge 80. Of course, other methods and apparatus can be used to temporarily reduce or stop blood flow through the vessel.

hi a preferred embodiment, the sponge 80 comprises a material made of, soaked in or otherwise treated with a hemostatic agent. The agent is specially adapted to aid blood clotting. Thus, blood that flows into the sponge encounters the agent and will quickly become clotted, causing natural sealing of the wound through blood clotting. Sponge-like hemostasis agents are available and can include products such as Gelfoam™, Oxycell™ and Avitene™. Another material that can be used as a sponge is chitosan. These and other appropriate sponges may be impregnated with agents such as thrombin, a liquid clotting agent, to help accelerate blood clot formation and Hemadex™, which is available from Medafor, Inc. Another material that may advantageously be used is a collagen Ultrafoam™ sponge marketed by C.R. Bard/Davol, hie. The Ultrafoam™ sponge is made from Avitene™ collagen, a natural clotting agent, and does not require the addition of thrombin. This reduces preparation time and the risk that a patient will experience a potentially hazardous reaction to bovine thrombin. Other medicaments can also be included in the sponge. For example, antibiotic medicines, anti-inflammatory drugs, healing aids, and the like can be impregnated into the sponge material.

In a particularly preferred embodiment, the hemostatic agent comprises a starch such as bioabsorbable microporous polysaccharide microspheres (e.g., TRAUMADEX™ marketed by Emergency Medical Products, Inc. of Waukesha, WT). The microspheres have micro-replicated porous channels. The pore size of the microspheres facilitates water absorption and hyperconcentration of albumin, coagulation factors, and other protein and cellular components of die blood. The microspheres also affect platelet function and enhance fibrin formulation, hi addition, the microspheres are believed to accelerate the coagulation enzymatic reaction rate. When applied directly, with pressure, to an actively bleeding wound, the particles act as molecular sieves to extract fluids from the blood. The controlled porosity of the particle excludes platelets, red blood cells, and serum proteins larger than 25,000 Daltons, which are then concentrated on the surface of the particles. This molecular exclusion property creates a high concentration of platelets, thrombin, fibrinogen, and other proteins on the particle surface, producing a gelling action. The gelled, compacted cells and constituents accelerate the normal clotting cascade. The fibrin

-12CA 02801969 2014-05-26 network formed within this dense protein-cell matrix adheres tightly to the surrounding tissue. The gelling process initiates within seconds, and the resulting clot, while exceptionally tenacious, breaks down normally along with the microparticles. Such microporous polysaccharide microspheres, and additional hemostatic agents, are discussed in more detail in Applicants’ copending application entitled “Deployable Multifunctional Hemostatic Agent,” U.S. Application Serial No. 10/868,201, filed June 14, 2004.

Any suitable hemostatic substrate can be employed as a support for the hemostatic agents of preferred embodiments. However, in a particularly preferred embodiment the hemostatic substrate comprises chitosan. Chitosan is obtained from chitin, a biopolymer obtained principally from shrimp and crab shell waste. Chitosan is the main derivative of chitin, and is the collective term applied to deacetylated chitins in various stages of deacetylation and depolymerization. The chemical structure of chitin and chitosan is similar to that of cellulose. The difference is that instead of the hydroxyl group that is bonded at C-2 in each D-glucose unit of cellulose, there is an acetylated amino group (NHCOCH3) at C-2 in each D-glucose unit in chitin and an amino group at C-2 in each D-

<img file="CA2801969C_D0001.tif" />

<img file="CA2801969C_D0002.tif" />

<img file="CA2801969C_D0003.tif" />

-13CA 02801969 2013-01-10

Chitin and chitosan are both nontoxic, but chitosan is used more widely in medical and pharmaceutical applications than chitin. Chitosan exhibits good biocompatibility and is biodegradable by chitosanase, papain, cellulase, and acid protease. Chitosan exhibits anti-inflammatory and analgesic effects, and promotes hemostasis and wound healing. Chitosan has also been used as a hemostatic agent hi surgical treatment and wound protection. The hemostatic effect of chitosan has been described in U.S. Patent No. 4,394,373.

A single hemostatic substrate or combination of hemostatic substrates of different forms and/or compositions can be employed in tlie devices of preferred embodiments. Different substrate forms can be preferred, for example, fibrous puff, fleece, fabric, sheet, suture, or powder. A homogeneous mixture of different substrate-forming materials can be employed, or composite substrates can be prepared from two or more different formed substrates. A preferred composite comprises chitosan and collagen. Additional details concerning chitosan and other suitable substrates are discussed in more detail in Applicants’ copending application “Deployable Multifunctional Hemostatic Agent.”

The sponge-like substrate material preferably is soft and pliable and will conform to the structure of the blood vessel, the wound and the field around the blood vessel. Thus, the sponge-like material is specially suited for use in the confined space surrounding a vascular puncture. Additionally, the hemostatic sponge 80 will be held in place by the tissue 96 surrounding the puncture wound w, which tissue 96 collapses over the sponge 80 when tools such as the retractor 70 are removed.

To further help hold the sponge 80 in place, flowable adhesive 106 from a source of adhesive 108 can be delivered through the lumen 90 of the push member 84 and onto the sponge 80, as shown in Figure 9. The adhesive 106 flows through the open distal end of the push member 84 and also through the holes 92 through the push member body portion 86. Upon curing, the adhesive 106 can form a sealing layer around and within the sponge 80, thus confining the blood b to the sponge area. This helps minimize bleeding and even further speeds clot formation. In one embodiment, adhesive, when cured, is substantially non-porous, and thus confines blood to a desired area. Adding adhesive 106 will also facilitate more complete closure of the passage through the sponge, which passage was vacated by the catheter 32. Further, tlie adhesive 106 will help hold tlie sponge 80 in place relative to the puncture wound w and the surrounding tissue 96.

-14CA 02801969 2013-01-10

As discussed above, prior to being advanced into contact with the blood vessel wall, tlie sponge 80 may be soaked in an adhesive or, more preferably, coated with a layer of adhesive. In this manner, adhesive distribution on the sponge can be controlled. By controllably applying a coating of adhesive around the outer surface of the sponge, tlie adhesive will bond the sponge to the area surrounding the blood vessel wound w, including tlie vessel 94 itself, and also can fonn a perimeter seal of the sponge when the adhesive cures. The coating of adhesive can act as a non-porous or selectively-porous membrane confining tlie blood b to the sponge 80. It is to be understood that a coating of adhesive may be used instead of or in addition to applying additional adhesive 106 through the push member 84.

Various kinds of flowable adhesives may be acceptable for use with the sponge. For example, fibrin tissue sealants such as Tisseel®, which is available from Baxter Healthcare Corp., may be appropriate. Other commercially available adhesives that may be appropriate include Bioglue™, available from Cryolife, Inc., and Floseal™, which is available from Fusion Medical Technologies. Various cyanoacrylate adhesives are currently commercially available and can be used with this invention. Of course, any product that is capable of sealing the sponge or at least retarding blood flow through or beyond tire sponge would be acceptable. It is also to be understood that certain adhesives will not require that the field and/or the outer wall of the blood vessel be cleared before tire adhesive is injected.

Curing time and ease of use will vary depending on the adhesive used. For example, some adhesives cure to a malleable gel-like state within a few seconds, while others will cure directly to a hardened state in a few minutes. The time period for curing is chosen to allow the clinician to advance the sponge into position adjacent tire wound and in contact with the artery, at which time tire sponge will begin to be bonded to the vessel wall and substantially sealed by the adhesive. It should be appreciated that airy acceptable adhesive having any acceptable curing time may be used. In accordance with this description, an adhesive is considered to be cured when it is adhered to surrounding tissue, and when it does not spontaneously flow.

The push member 84 may be kept in place for any reasonable time period in order to allow the adhesive 106 to cure. Also, multiple sponges can be used, if desired. Preferably, however, the adhesive 106 will cure sufficiently in about five minutes or less. Other tools,

-15CA 02801969 2013-01-10 such as an ultraviolet light source or a heat application device, may be used to help speed adhesive curing.

Once the sponge 80 is correctly placed, the push member 84 can be removed. Removal of the push member 84 can be aided by a release rod 110 which, as shown in Figure 10, is advanced through the push member lumen 90 and into contact with the sponge 80- The release rod 110 holds the sponge 80 in place as the push member 84 is withdrawn from the patient. Thus, the release rod 110 engages the sponge 80 so as to provide counter traction when the push member 84 is withdrawn. In this way, the push member 84 can be removed even if some adhesion occurs between tire sponge 80 and the push member 84. With reference next to Figure 11, once the release rod 110 is withdrawn, the patient's skin 112 is closed by any appropriate closure media such as, for example, sutures 114. The hemostatic sponge 80 is left in place. The body's natural blood clotting process will plug and repair the vascular wound w with, the aid of tire hemostatic sponge 80. Thus, healing will proceed without the danger of false aneurysms, missed or faulty wound closure, or the like.

In the embodiment illustrated in Figures 1-9, the catheter comprises a single-lumen catheter. In another embodiment (not shown), the elongate catheter has a first lumen comprising a tube that extends from the distal end opening to the proximal end opening and slidingly accommodates the guidewire therewithin. The outer wall of the catheter defines a second lumen that concentrically surrounds the first lumen. The holes through the outer wall of tire catheter open into the second lumen. Additionally, an access lumen communicates with tire second lumen, hr this embodiment, the distal and proximal openings, which accommodate tire guidewire, do not communicate with the second lumen, which lumen communicates with tire source of suction through tire access lumen. Accordingly, in this embodiment, there may be less of a chance that body fluids will be drawn into the catheter through the distal and proximal guidewire openings than in an embodiment employing a single lumen. However, the single-lumen catheter can be less expensive to manufacture and can be expected to have a smaller diameter than tire duallumen catheter.

With reference next to Figures 12-16, another embodiment of a vascular wound closure apparatus is presented. The apparatus includes a retractor 200 and an elongate catheter 250.

-16CA 02801969 2013-01-10

With particular reference to Figure 13, the catheter 250 has a proximal end 250a and a distal end 250b. A distal opening is formed through the distal end of the catheter and opens along a longitudinal axis of the catheter. A lumen 250c is defined within the catheter. A tip 256 at the distal end 250b of the catheter 250 preferably is tapered. A connector portion is provided on the proximal end 250a, which connector portion preferably includes a main lumen and a secondary lumen. The main lumen extends along the longitudinal axis of the catheter and is coextensive with the catheter lumen 250c. At least one indicator hole 258 is formed through a side wall of the catheter near the distal end. Preferably the catheter 250 is generally straight and is sized between about 4-8F and more preferably about 6F.

An outer surface 252 of the catheter 250 preferably has a generally cylindrical shape and includes a raised portion 254. In one preferred embodiment, the raised portion 254 defines a connection between two separate sections (not shown) of the catheter 250. In the illustrated embodiment, the raised portion 254 is cylindrical and includes a length 254a.

With continued reference to Figure 13 a pusher member 260 preferably is movably disposed about the outer surface 252 of the catheter. The pusher member 260 preferably is configured to slide over the catheter 250. The pusher member 260 preferably has an inner lumen having a diameter greater than the raised portion 254 of the catheter 250 so that the pusher member 260 can slide over the raised portion 254.

With reference next to Figures 14-16, the retractor 200 preferably is configured to be mounted onto the catheter 250. In the illustrated embodiment, the retractor 200 preferably has two retractor arms 202 movably connected to each other, each having a length 204 from a proximal end 206 to a distal end 208. The retractor aims 202 preferably are capable of being moved between an open position (see Figure 14) and a closed position (see Figure 12). When in the closed position, as illustrated in Figure 12, the retractor arms 202 preferably enclose at least a portion of the catheter 250. Although Hie illustrated embodiment of the retractor 200 shows only two retractor arms 202, it should he understood that the retractor 200 can have more than two retractor arms 202.

With continued reference to Figures 14 and 15, each of the retractor arms 202 preferably defines an inner surface 210 generally facing the inner surface 210 of the other aim 202. Each inner surface 210 defines edges 212 that preferably extend along the length 204 of the arms 202. The inner surface 210 also preferably defines a cavity or channel 220

-17CA 02801969 2013-01-10 extending between the edges 212. The channel 220 preferably extends the length of the retractor aims 202. When the retractor arms 202 are in the closed position, as shown in

Figure 12, the channels 220 on the retractor aims 202 preferably combine to define a canal

221 extending the length 204 of the aims 202.

With reference to Figures 14-15, the channel 220 preferably comprises a proximal portion 222 disposed at the proximal end 206 of the retractor arms 202. In a preferred embodiment, the proximal portion 222 has a generally curved shape configured to removably receive and substantially contact and hold at least a portion of the catheter 250 in a fixed position when the retractor arms 202 are in the closed position. The proximal portion 222 also has a depth. 222a generally orthogonal to the length 204 of the retractor arms 202. For example, the proximal portion 222 can have a semi-circular cross-section with a radius 222a about the same as that of an outer surface 252 of the catheter 250. However, the proximal portion 222 can have any shape configured to substantially contact the catheter 250 when the retractor arms 202 are in the closed position. Most preferably, the proximal portion 222 is sized and configured generally complementary to the catheter 250 so that the retractor 200 holds the catheter 250 generally snugly at the proximal portion 222.

With continued reference to Figures 15 and 16, tire channel 220 preferably comprises a receiver portion 224 adjacent tire proximal portion 222. The receiver portion 224 preferably has a generally curved shape and has a depth 224a generally orthogonal to the length 204 of fire arms 202 that is greater than the depth 222a of the proximal portion 222. Accordingly, the receiver portion 224 defines an edge 224b between the receiver portion 224 and tire proximal portion 222. The illustrated receiver portion 224 has a semicircular cross-section with a radius 224a that is greater than the radius 222a of the proximal portion 222. Most preferably, the receiver portion 224 is generally complementary to the catheter raised portion 254 so as to receive the raised portion 254 therein.

The channel 220 also preferably comprises a contact portion 226 adjacent the receiver portion 224. Similar to the proximal portion 222, the contact portion 226 preferably is generally complementary to the catheter outer surface 252 and is configured to removably receive, and to substantially contact and hold tire catheter 250 when the retractor arms 202 are in the closed position. The contact portion 226 preferably has a depth 226a generally orthogonal to the length 204 of the retractor arms 202. In one preferred

-18CA 02801969 2013-01-10 embodiment, the depth 216a is similar to the depth 222a of the proximal portion 222. For example, the contact portion 226 can have a semi-circular cross-section with a radius 226a about the same as the radius 222a of the proximal portion 222. The depth 226a of the contact portion 226 is also preferably smaller than the depth 224a of the receiver portion 224, so that the receiver portion 224 defines an edge 224c between the receiver portion 224 and the contact portion 226.

With reference still to Figures 15 and 16, in the illustrated embodiment, the proximal portion 222 and contact portion 226 each are smaller than the receiver portion 224. Most preferably, the proximal portion 222 and contact portion 226 are configured so that the catheter raised portion 254 cannot slide through either portion 222, 226. Thus, when the raised portion 254 is disposed in the receiver portion 224 as shown in Figure 16, the raised portion is constrained from moving proximally or distally. As such, the entire catheter 250 is longitudinally locked in place relative to the retractor 200 when the retractor arms 202 are closed about the catheter as shown in the Figure 12.

The channel 220 further preferably comprises a compartment portion or chamber 228 adjacent the contact portion 226. The chamber 228 preferably has a generally curved shape and a depth 228a generally orthogonal to the length 204 of the retractor arms 202 greater than the depth 226a of the contact portion 226. For example, the chamber 228 can have a semi-circular cross-section with a radius 228a greater than the radius 226a. Further, the contact portion 226 defines an edge 226b between the contact portion 226 and the chamber 228. The chamber 228 is configured to receive a portion of the catheter 250 therein and to define a space 228b between the catheter 250 and the retractor arms 202. When the retractor arms 202 are in the closed position, the space 228b extends generally about the entire circumference of the catheter 250. The space 228b is configured to receive and accommodate a hemostatic material 270 therein so that it surrounds at least a portion of the outer surface 252 of the catheter 250. The hemostatic material 270 is further described below.

A distal portion 230 of the channel is defined adjacent the chamber 228 and has a depth 230a generally orthogonal to the length 204 of the refractor anns 202 smaller than the depth 228a of the chamber 228. The distal portion 230 preferably is generally complementary to the catheter outer surface 252 so as to substantially contact and hold the catheter 250 when the retractor arms 202 are in the closed position. For example, the distal

-19CA 02801969 2013-01-10 portion 230 can. have a semi-circular cross-section wifli a radius 230a. In one preferred embodiment, the radius 230a is about the same as the radius 226a of the contact portion 226 and/or the radius 222a of the proximal portion 222. A generally smooth transition section

230b preferably connects the chamber portion 228 and the distal portion 230.

With reference again to Figures 12-16, in practice, the hemostatic material 270 is preferably disposed about the outer surface 252 of the catheter 250 at a location between the raised portion 254 and the catheter holes 258. The catheter 250 is placed in the channel 220, while the arms 202 are in the open position, so that the raised portion 254 is disposed in the receiver portion 224 and the hemostatic material 270 is housed in the chamber 228. Preferably, the catheter 250 and retractor 200 are configured so that, when assembled, the distance between the distal end 208 of the retractor arms 202 and the indicator holes 258 is at least the same as the width of an artery wall. Preferably, said distance is at least about 0.5 to 2 millimeters.

When the retractor arms 202 are moved into the closed position with the raised portion 254 disposed in the receiver portion 224, the catheter 250 is longitudinally locked relative to the retractor 200. Thus, the catheter 250 and retractor 200 will move together even if longitudinal forces are exerted upon one or the other structure. In use, the apparatus is advanced into the patient so that the catheter 250 is advanced into the wound w as discussed above in connection with the embodiment discussed in connection with Figures 1-4. When blood b is observed in a viewing port (not shown) connected to the catheter 250, tlie retractor arms 202 are then preferably moved into the open position. The pusher member 260 is then advanced toward the distal end 250b of the catheter 250 to engage and advance the hemostatic material 270 into contact with the wound w.

hi the embodiment illustrated in Figures 12-16, the hemostatic material 270 preferably comprises a malleable, fibrous material. For example, preferably the substrate comprises a puff - a fibrous, cotton-like material that can be manipulated into a suitable shape or size so as to accommodate a particular wound configuration. Most preferably, the hemostatic material 270 comprises a puff prepared from chitosan fibers and infused with microporous polysaccharide microspheres. Applicants’ copending application “Deployable Multifunctional Hemostatic Agent” discusses such a hemostatic puff and methods of depositing microporous polysaccharide microspheres thereon. Other fibrous substrates and hemostatic agents may also be employed in other embodiments.

-20CA 02801969 2013-01-10

Ια still other embodiments, the hemostatic material 270 can be infused with any number of medications associated with the treatment of wounds. For example, antibiotic and anti-inflammatory medications maybe further infused or deposited on a substrate.

It is further to be understood that, in accordance with further embodiment, the raised 5 portion 270 can have various configurations. For example, the raised portion may not extend circumferentially about the catheter 250, and a plurality of raised portions may be employed. Preferably, the receiver portion of the retractor 200 is shaped complementary to the raised portion. Additionally, the inner lumen of the pusher member 260 may have a cross sectional shape configured to fit over the raised portion, and may in some embodiments be non-circular.

With reference next to Figures 17-23, another embodiment of a vascular wound closure assembly 300 comprises a catheter 310 having a proximal end. 312 and a distal end 314, and defining a lumen (not shown) therebetween. A pusher member 330 having a proximal end 332 and a distal end 334 is slidably disposed on the catheter 310. A delivery tube 350 having a proximal end 352 and a distal end 354 is slidably disposed on the catheter 310 and is positioned distal of the pusher member 330. The closure assembly 300 . preferably is made of a polymeric material, such as polypropylene. Preferably, the assembly 300 is also made of hypoallergenic materials.

With particular reference to Figure 18, the catheter 310 preferably comprises a stop member 316 disposed in a fixed position about the catheter surface 310a. The distal end 314 preferably is tapered, and catheter holes 318 are formed through a side of the catheter 310 proximal of the distal end 314. In one embodiment, the catheter 310 preferably comprises a secondary branch 319 disposed at the proximal end 312, and having a secondary/ lumen (not shown) connected to the lumen of the catheter 310. The secondary branch 319 preferably is configured to operatively connect to a variety of devices used in the closure of vascular wounds, such as a suction device. For example, in one embodiment, a syringe can be connected to the secondary branch 319 to pull a vacuum through the catheter 310.

A coupling member 320 preferably is movably disposed about the catheter 310 and is configured to mechanically couple to the stop member 316. In the illustrated embodiment, the stop member 316 is threaded on its outer surface and the coupling member 320 is threaded on its inner surface so that the respective threads are engageable so

-21CA 02801969 2013-01-10 that the coupling member 320 and catheter 310, when engaged, do not move longitudinally relative to one another. As such, the member 320 and catheter 310 axe releasably coupled to one another. In other embodiments, other suitable mechanical coupling mechanisms can be used. For example, a detent and catch mechanism or a j-lock mechanism can also be acceptably employed.

hi this description, the term releasably coupled is a broad term used in its ordinary sense and referring to, without limitation, to members being attached or affixed to one another in a manner so that they can be decoupled from one another. For example, without limitation, members can be coupled with threads, a detent mechanism, a conformed yet breakable bridge, such as flashing from injection-molding, an adhesive, or the like.

With particular reference next to Figure 19, the pusher member 330 preferably comprises a generally cylindrical central portion 336, a generally conical transition portion 337 and a generally cylindrical distal portion 338. The diameter of tire central portion 336 preferably is larger than the diameter of the distal portion 338. The pusher member 330 preferably defines a canal 330a that extends from the proximal end 332 to the distal end 334 and which is preferably configured, to slidably receive the catheter 310 therethrough. For example, the canal 330a can have a circular cross-section with a diameter larger than the diameter of the catheter surface 310a. However, the canal 330a is not large enough to fit over the catheter stop member 316. As such, the pusher member 330 cannot be moved proximally over the catheter 310 beyond the stop member 316,

The pusher member 330 preferably comprises a handle 340 near the proximal end 332. It is to be understood that the pusher member 330 can comprise more than one handle 340.

A proximal coupling member 342 is disposed at the proximal end 332. hi the illustrated embodiment, the proximal coupling member 342 comprises threads on its outer surface sized and configured to engage the threads of the coupling member 320. As shown in Figure 27, the catheter coupling member 320 is configured to engage both the stop member 316 and the pusher member proximal coupling member 342 so as to selectively hold the pusher 330 longitudinally fixed relative to the catheter 310,

A distal coupling member 344 is disposed proximal the transition portion 337. In the illustrated embodiment, the distal coupling member 344 comprises a generally hemispherical raised portion.

-22CA 02801969 2013-01-10

With particular reference next to Figures 20-21, the delivery tube 350 preferably has a body 350a with a conical outer surface 350b having a generally decreasing diameter 350c between a top edge 357 at the proximal end 352 and the distal end 354. A wall 350e of the delivery tube 350 has a thickness t. The delivery tube wall 350e preferably defines a chamber 350d extending from the proximal end 352 to the distal end 354 The chamber 350d preferably is conical in shape, and preferably is configured to receive hemostatic material 270 therein between the catheter and the wall. The proximal end 352 of the delivery tube 350 also is preferably configured to receive at least a distal portion of the pusher member 330. The distal end 354 of the delivery tube 350 has a distal opening that is configured to receive the catheter 310 extending therethrough.

With particular reference to Figure 21, the delivery tube 350 preferably comprises weakened portions 356. In the illustrated embodiment, the weakened portions 356 comprise portions of the tube 350 having a reduced thickness ti, The reduced thickness weakened portions 356 preferably extend from at or near the proximal end 352 to the distal end 354 of the delivery tube 350. The weakened portions 356 define a preferential breaking or deformation zone of the delivery tube 350 so that when a force beyond a specified threshold is applied, the tube will deform or break in the vicinity of the weakened portions 356. In the illustrated embodiment, the delivery tube 350 has two weakened portions 356 comprising elongate sections of reduced thickness t' diametrically opposed to each other. Preferably, the elongate weakened portions 356 extend the entire length of the delivery tube 350.

In accordance with this description, the term weakened portion is a broad term used in its ordinary sense and referring to, without limitation, a zone or area that preferentially breaks, bends, stretches, expands or otherwise deforms upon application of a threshold force, hi fire illustrated embodiment, the weakened portions comprise portions that are relatively thin, hr accordance with other embodiments, a weakened portion can include, without limitation, a portion of material that is scored, perforated, physically or chemically treated, or tire like. Further, a weakened portion can comprise an elastic or easily deformable material that may or may not be a different material than tire rest of tire member.

-23CA 02801969 2013-01-10

In the illustrated embodiment, as shown in Figure 21, the delivery tube 350 has two weakened portions 356. However, it is to be understood that the delivery tube 356 can have one or a plurality of weakened portions 356.

In one embodiment, the delivery tube 350 preferably comprises separation starter portions 358 disposed at the proximal end 352. The starter portions 358 are preferably disposed adjacent and aligned with the weakened portions 356. hi the illustrated embodiment, the starter portions 358 are notches 358 aligned with the weakened portions 356. In other embodiments starter portions 358 can be provided having other shapes.

The delivery tube 350 further comprises a coupling portion 360 disposed at the proximal end 352. The coupling portion 360 preferably is configured to mechanically couple to the pusher member distal coupling member 344. With reference to Figure 22, the illustrated coupling portion 360a comprises a catch configured to releasably hold the raised portion of the pusher member distal coupling member 344. To engage the coupling portions 244, 260, the delivery tube 350 is moved longitudinally relative to the pusher member 344 until the catch is aligned with the raised portion, at which time the raised portion will enter the catch. The catch and raised portion are configured so that the raised portion will exit the catch only upon application of a threshold force. Thus, the pusher member 330 and tube 350 are releasably coupled and longitudinally fixed relative to one another.

With reference again to Figure 20, the delivery tube 350 comprises a handle 362 disposed adjacent the proximal end 352. The handle 362 preferably comprises two opposing support arms that extend outward from the conical outer surface 350b at locations spaced from the weakened portions 356. In tlie illustrated embodiment, the delivery tube handle 362 comprises two support arms diametrically opposed to each otiier and disposed generally 90° from the weakened portions 356.

With reference again to Figure 17, die vascular wound closure assembly 300 is assembled by sliding the distal end 314 of the catheter 310 through the canal 330a of the pusher member 330 so that the proximal end 332 of die pusher member 330 preferably abuts the stopper member 316, and so the distal end 314 of the catheter 310 extends out from the distal end 334 of the pusher member 330. The coupling member 320 engages the stop member 316 and pusher member proximal coupling member 342 so that die pusher member 330 is fixed longitudinally to die catheter 310.

-24CA 02801969 2013-01-10

The proximal end 352 of the delivery tube 350 is slid over the distal end 314 of the catheter 310 so that the catheter 310 travels through the opening 350d. As the delivery tube 350 is slid proximally over the catheter 310 the coupling portion 360 mechanically engages the distal coupling member 344 of the pusher member 330. As such, tire catheter 310, pusher member 330 and delivery tube 350 are fixed longitudinally to one another. Thus, the pusher member and tube move together as a unit. The hemostatic material 270 can be added to the chamber 350d of the delivery tube 350 before or during the assembly process.

With continued reference to Figure 17, when the apparatus is assembled, the distal end 314 of the catheter 310 extends from the distal end 354 of the delivery tube 350, and the catheter holes 318 preferably are spaced from the distal end 354 a distance at least the same as the width of an artery wall. Preferably, the distance is about 0.5 to 2 millimeters.

To use the apparatus, the assembled device is advanced into the vascular wound w in a manner similar to that discussed above in connection with Figures 1-4. When the device is positioned so that the distal end 354 of the delivery tube 350 is generally adjacent the wound w, the coupling member 320 preferably is disengaged from the stop member 316 of the catheter 310 and the proximal coupling member 342 of the pusher member 330, Similarly, the coupling portion 360 of the delivery tube 350 preferably is disengaged from the distal coupling member 344 of the pusher member 330. Accordingly, the pusher member 330 and delivery tube 350 are no longer longitudinally fixed relative to each other.

With reference next to Figure 23, the pusher member 330 is then preferably advanced distally into the opening 350d of the delivery tube 350 while the delivery tube 350 is held generally stationary adjacent the wound w. Since the pusher member 330 is generally larger in diameter than the delivery tube 350, the delivery tube 350 breaks along the weakened portions 356 as the pusher member 330 is advanced. In one embodiment, a user grasps the handle 340 of the pusher member 330 and the handle 362 of the delivery tube 350 to drive the pusher member 330 through the delivery tube 350.

As the delivery tube 350 breaks, openings are created so that the hemostatic material 270 is free to exit the chamber. As the pusher member 330 advances, it engages and advances the hemostatic material 270 out of the tube 350 and into contact with the wound w. Preferably, the broken portions of the delivery tube 350 are removed from the wound location.

-25CA 02801969 2013-01-10

As described above in connection with other embodiments, the catheter 310 can be slidably withdrawn through the canal 330a of the pusher member 330. Further, a release rod (not shown) can also be used to provide counter traction to help remove the pusher member 330 from die wound location. For example, the release rod can be slidably inserted through the canal 330a of the pusher member 330 so that it engages the hemostatic material 270 against the wound location. A user can then remove the pusher member 330 without disturbing the hemostatic material 270 because the counter traction provided by the release rod will keep the hemostatic material 270 in place as the pusher member is removed.

in the embodiment discussed above, the coupling members are disengaged before advancing the pusher member relative to the delivery tube. It is to be understood that, in other embodiments, the coupling members can be adapted so that mere application of a force above a threshold force level will defeat the coupling members so as to release the releasably coupled members from one another. Thus, as the user applies force to advance the pusher member, the user simultaneously disengages the coupling members and advances the pusher member.

In another embodiment, the distal coupling member of the pusher member is threaded on its outer surface, and the proximal coupling member of the delivery tube is threaded on its inner surface. As such the pusher member and delivery tube are threadably affixed to each other. In this arrangement, the pusher member is advanced relative to the delivery tube by threading the pusher member. This arrangement allows the user to adjust the distance between the distal ends of the delivery tube and the catheter indicator holes. When the device is positioned so that the delivery tube is adjacent the wound, the pusher member is advanced by continuing to thread the pusher member into die delivery tube as the delivery tube is held in place. As such, the pusher member will advance, and will eventually break the tube at the weakened portions. The pusher member can then be advanced further by using the handles.

In still other embodiments, other types and structures of coupling members can be employed. For example, various releasable locking structures can be employed, such as a

J-lock or an L-lock (see Figure 24). Additionally, in still further embodiments, the coupling members can have still different structure. For example, the coupling member can comprise an adhesive between the pusher member and catheter, which adhesive is

-26CA 02801969 2013-01-10 configured to be defeated upon application of a threshold force. In yet a further embodiment, the pusher member and catheter are lightly heat bonded or otherwise bonded together. As such, die bond between the pusher member and catheter will be overcome upon application of a threshold force.

Figures 25-28 illustrate another embodiment of a vascular closure apparatus 300' having many aspects similar to the embodiment described above with reference to Figures 17-23. Where possible, the same reference numerals are used to identify similar elements, but elements of the present embodiment include the appellation

With specific reference to Figure 25, the closure apparatus 300' preferably comprises a catheter 310', a pusher member 330', and a delivery tube 350' releasably connected to each other. Additionally, the apparatus 300' preferably comprises a threaded coupling member 344' slidably disposed about tire pusher member 330'.

With specific reference next to Figure 26, the catheter 310' preferably comprises an unthreaded stop member 316'. Additionally, a coupling member 320' preferably is configured so that a portion of the coupling member is slidable over the stop member 316' so as to enclose it. However, a proximal portion of the coupling member cannot slide over the stop member 316', and thus the stop member limits the distal travel of the coupling member.

With reference next to Figure 25 and 27, the proximal end 332 of the pusher member 330' is configured to abut against the stop member 316' when the pusher member 330' is slidably disposed on the catheter 310'. The threaded outer surface of the proximal coupling member 342 preferably is configured to mechanically engage the threads of the coupling member 320' when said member 320' is advanced over the proximal end 332 of the pusher member 330'.

The pusher member 330' preferably comprises a transition portion 337' adjacent the distal portion 338. The transition portion 337' preferably comprises a cylindrical raised portion 337a' and a generally conical portion 337b'. The raised portion 337a' comprises an unthreaded outer surface, and preferably is configured to slidably receive a distal portion of the coupling member 344' about and over its outer surface so that the coupling member 344' encloses the raised portion 337a', A proximal portion of the coupling member 344' cannot slide over the raised portion 337a', and thus the raised portion 337a' limits distal travel of the coupling member 344' over the pusher member 330'.

-27CA 02801969 2013-01-10

With reference to Figures 25 and 28, the delivery tube 350' preferably comprises a coupling portion 360' at its proximal end 352. The coupling portion 360' preferably includes a threaded outer surface 360a' configured to mechanically engage tlie coupling member 344'. In one preferred embodiment, the delivery tube 350' comprises weakened portions 356, as previously discussed, hi another preferred embodiment, the body 350a' of the delivery tube 350' comprises two separate halves 350f, 350g configured to abut against each other about an axis z and be held in a generally fixed position relative to each other when the coupling member 344' is threaded onto the coupling portion 360', In yet another preferred embodiment, the delivery tube 350' comprises a body 350a' with two halves 350f, 350g joined at the proximal end 352 of the delivery tube 350' by weakened portions 356'. In another embodiment, the two halves are joined by an elastic member which helps hold the halves together before the hemostatic material is deployed.

With reference again to Figure 25, the vascular closure apparatus 300' preferably is assembled so that the catheter 310', the pusher member 330', and the delivery tube 350' are releasably coupled by the coupling members so as to be fixed relative to each other. For example, the catheter 310' is slidably inserted into the pusher member 330' until the stopper member 316' abuts against the proximal end 332 of the pusher member 330'. The coupling member 320' is then slid over the stopper member 316' and threaded onto the proximal coupling member 342 of the pusher member 330'. The delivery tube 350' is similarly slid over the catheter 310' and pusher member 330' until the proximal end 352 of the delivery tube 350' abuts against the transition portion 337', wherein the delivery tube 350' preferably encloses the hemostatic material 270 therein. The coupling member 344' is then slid over the raised portion 337a' and threadably engages the coupling portion 360'.

As previously discussed, once the device is in place adjacent tlie wound w, the coupling members 344', 320' are disengaged so that the pusher member 330' is uncoupled from the catheter 310' and the delivery tube 350'. The user advances the pusher member 330' into the delivery tube 350' to deform the tube and engage and advance the hemostatic material 270 adjacent the wound w.

In the embodiments just discussed, the delivery tube is configured to break when the pusher member is advanced, hi other embodiments, the delivery tube may not break, but deforms sufficiently so that material within the tube can be dispatched therefrom. For example, at least a portion of the tube may be formed of an elastic material, such as

-28CA 02801969 2013-01-10 silicone, so that the pusher member deforms the tube and forces material out of the tube and adjacent the wound. Additionally, in one embodiment wherein the tube is formed of an elastic material, the tube does not necessarily include a weakened portion. This principle can also be employed in connection with other embodiments discussed herein, including the following embodiments.

Figures 29-37 illustrate another embodiment of a vascular closure apparatus 300 having many aspects similar to the embodiments described above with reference to Figures 17-23 and to Figures 25-29. Where possible, the same reference numerals are used to identify similar elements, but elements of the present embodiment include the appellation . Of course, it is to be understood that similar elements do not necessarily share identical structure.

With specific reference to Figure 29, the closure apparatus 300 preferably comprises a catheter 310, a pusher member 330, and a delivery tube 350 releasably connected to each other.

With reference also to Figure 30, the catheter 310 preferably comprises an unthreaded stop member 316 that is raised relative to the catheter body. Additionally, a coupling member 320 preferably is configured so that a portion of the coupling member is slidable over the stop member 316 so as to enclose it. However, a proximal portion of the coupling member 320 cannot slide over the stop member 316, and thus the stop member limits the distal travel of the coupling member 320.

With reference next to Figures 29 and 31, the pusher member 330” preferably is elongate and is slidable over the catheter 310. A proximal end 332 of the pusher member 330 is configured to abut against the stop member 316 when the pusher member 330^r is slid proximally over the catheter 310, The threaded outer surface of the proximal coupling member 342 of the pusher 330 preferably is configured to mechanically engage the threads of the coupling member 320 when said coupling member 320 is advanced over the proximal end 332 of the pusher member 330. As such, the pusher member 330 is releasably coupled to the catheter 310 with die proximal end 332 abutting the stop member 316,

The threaded outer surface of the proximal coupling member 342 preferably is also configured to mechanically engage a threaded handle 340. With reference also to Figures 32a, 32b, and 33, the illustrated handle 340 comprises a handle support 370 and

-29CA 02801969 2013-01-10 a handle aim 371. The handle support 370 comprises an elongate body 365 and a flange

367. Preferably, the body 365 has a square or rectangular shaped, profile that corresponds with a square or rectangular shaped hole 369 defined in the handle ann 371, such that in an engaged configuration, the handle support 370 rotates together with the handle arm 371.

The flange 367 also preferably has a square or rectangular profile. The handle ann 371 preferably is slidable relative the handle support body 365 in an axial direction, and thus preferably can be removed from the handle support 370 and passed over the stop member 316 of the catheter when the coupling member 320 is uncoupled from the proximal coupling member 342. It is to be understood that, in other embodiments, any suitable mechanism, such as a detent, can be used to releasably couple the arm handle 371 to the support 370.

The pusher member 330 preferably comprises a central shaft section 372 that is unthreaded, and has a reduced diameter relative the threaded outer surface of the proximal coupling member 342. The central shaft section 372 preferably is located between the proximal coupling member 342, having a raised threaded outer surface, and a distal coupling member 374, also having a raised threaded outer surface.

With continued reference to Figures 29 and 31, the pusher member 330 preferably comprises an adjustable stopper 337 adjacent the distal portion 338. The adjustable stopper 337 preferably comprises a cylindrical raised portion 337a and a generally conical portion 337b. The raised portion 337a comprises an unthreaded outer surface and a threaded inner surface. The threaded outer surface of the distal coupling member 374 of tire pusher member 330 preferably is configured to mechanically engage the threads of the adjustable stopper 337 when the adjustable stopper 337 is advanced over a distal portion 338 of tire pusher member 330,

A coupling member 344 is slidably disposed about the pusher member 330. The raised portion 337a of the adjustable stopper 337 preferably is configured to slidably receive a distal portion of the coupling member 344 about and over its outer surface so that the coupling member 344 encloses the raised portion 337a. However, a proximal portion of the coupling member 344 cannot slide over the raised portion 337a, and thus the raised portion 337a limits distal travel of the coupling member 344 over the pusher member 330.

-30CA 02801969 2013-01-10

With reference next to Figure 34, the proximal portion of the coupling member 344 preferably defines a hole 368 that is sized and configured such that the coupling member 344 cannot slide distally over the adjustable stopper 337, but can slide proximally over the central shaft section 372, the handle support 370, and die catheter stop member 316. In the illustrated embodiment, the hole 368 is generally complementary to the handle support flange 367. Thus, when the coupling member 320 and the handle 371 have been removed, the coupling member 344 can also be removed if desired. The handle arms 371 can be replaced on the handle support 370 after the coupling member 344” has been removed.

The distal portion of the coupling member 344 preferably comprises a threaded portion 376 on an inner surface. The threaded portion 376 preferably comprises threads covering a proximal portion of the inner surface of the coupling member 344. Preferably, a distal portion of the inner surface of the coupling member 344 is not threaded.

With reference next to Figures 29 and 35-36, the deliveiy tube 350 comprises a body 350a made up of two separate halves or segments 350f, 350g\' The segments 350f, 350g are formed separately but are configured to abut against one another about an axis “z” to form the delivery tube 350. Preferably a first segment 350g has guide portions 380 that are configured to fit into recesses 381 formed in a second segment 350f in order to properly align the segments to form the delivery tube 350.

Each segment 350f, 350g has a generally concave inner surface configured so that the tube 350, when assembled, fits concentrically about the catheter 310. In the illustrated embodiment, the inner surface defines a chamber between the catheter 310 and inner surface when the tube 350” is in place. Preferably, at least a distal portion of the chamber is tapered so that the diameter of the chamber decreases smoothly toward the distal end thereof.

The delivery tube 350 has a coupling portion 360 at its proximal end 352. The coupling portion 360 preferably includes a threaded outer surface 360a configured to mechanically engage the coupling member 344. When the coupling member 344 is threaded onto the coupling portion 360, as shown in Figure 37, the segments 350f, 350g are held in a generally fixed position relative to each other. It is to be understood that other structures maybe used to releasably couple the segments 350f, 350g. Also, in

-31CA 02801969 2013-01-10 other embodiments, the delivery tube 350 may comprise a body 350a having several releasably coupled segments at or near the proximal end 352 of the delivery tube 350.

With reference again to Figure 29, the adjustable stopper 337 preferably contacts an upper portion of tlie assembled delivery tube 350. The adjustable stopper 337 can be advanced proximally or distally relative the pusher member 330 by rotating the adjustable stopper 337. When the catheter 310, tlie pusher member 330 and the delivery tube 350 are to be coupled together, moving the adjustable stopper 337 proximally or distally relative the pusher member 330 prior to coupling the pusher member 330 with the delivery tube 350 effectively adjusts the position of the delivery tube 350 relative the catheter 310. Accordingly, another feature of this embodiment is that the position of the distal end of the delivery tube 350 can be adjusted relative the holes in the catheter 310 by movement of the adjustable stopper 337. This may be desirable to adjust the delivery tube 350 position relative the holes in the catheter 310 based on the thickness of a particular blood vessel wall and/or the preference of a clinician. For example, a clinician may adjust the stopper 337 so as to position the distal end of the delivery tube 350 at a desired position between about 1 mm and 1 cm proximal of tlie holes of the catheter 310.

The threaded inner surface 376 of die coupling member 344 preferably is configured to mechanically engage the threads of tlie coupling portion 360 when the coupling member 344 is advanced over the stopper 337 and further over a proximal end 352 of the delivery tube 350. Accordingly, another feature of this embodiment is that the delivery tube 350 is securely coupled with the pusher member 330 through the coupling member 344. The coupling member 344 also helps hold the body segments 350f350g together. Because only a portion of the inner surface of the coupling member 344 is threaded, the pusher member 330 and the delivery tube 350 can be quickly and easily decoupled.

With reference next to Figures 37-39, the vascular closure apparatus 300 preferably is assembled so that the catheter 310, the pusher member 330, and the delivery tube 350” are releasably coupled by the coupling members so as to be fixed relative to each other. For example, tlie catheter 310 is slidably inserted into the pusher member 330 until the stopper member 316 abuts against the proximal end 332 of Hie pusher member 330. The coupling member 320 is then slid over the stopper member 316 and threaded onto the proximal coupling member 342 of the pusher member 330.

-32CA 02801969 2013-01-10

The hemostatic material 270 preferably is wrapped, about the catheter 310 adjacent a distal end of the pusher member 330, and the delivery tube 350 is positioned over the catheter 310 so that the hemostatic material is enclosed within tlie chamber. The delivery tube 350 is positioned over part of the catheter 310 and pusher member 330 so that the proximal end 352 of the delivery tube 350 abuts against the adjustable stopper 337. The coupling member 344 is then slid over the raised portion 337a and tbreadably engages the coupling portion 360. Before coupling the pusher and tube, the clinician may adjust the position of the tube relative to the catheter by advancing or retracting the adjustable stopper 337. Preferably, the delivery tube 350 is arranged on the catheter 310 so that the distal end of the tube 350 is between about 1 nun to 1 cm proximal of the catheter holes.

As previously discussed, once the fully assembled device is in place adjacent the wound w, the coupling members 344, 320 are disengaged, so that the pusher member 330 is uncoupled from the catheter 310 and the delivery tube 350, as shown in Figure 38. The handle 340 preferably is removed momentarily so that the coupling member 344 can be removed over the handle support 370. The handle 340 preferably is replaced and the adjustable stopper 337 preferably is moved proximally to the central shaft section 372 so that it can slide freely and. will not restrict advancement of the pusher member 330 relative the delivery tube 350.

As best shown in Figure 39, as the clinician advances the pusher member 330 into the delivery tube 350, the distal end of the pusher member 330 engages the hemostatic material 270 and advances toward the wound w”. As the user advances the pusher member 330 into the delivery tube 350, a'distal portion 338 of the pusher member 330 preferably contacts the tapered inside surface of die delivery tube chamber, thus at least partially separating the segments 350f, 350g' of the delivery tube 350. This allows the hemostatic material 270 to be deployed from the chamber and onto the blood vessel at or adjacent the wound.

The distal portion 338 of the pusher member 330 preferably contacts the inside surface of the delivery tube 350 in a distal portion of the tube. For example, in one embodiment, the pusher member 330 first engages the tapered inner surface at a point distal the halfway point of tine length of the tube, hi another embodiment, the first engagement point is between about 2/3 and 3/4 of the way into the delivery tube 350.

-33CA 02801969 2013-01-10 hi accordance with one embodiment, preferably the apparatus is configured so that the stopper 337 is advanced over just one or a few threads of the pusher member distal coupling member 374 when the apparatus is assembled. As such, to deploy the hemostatic material 270, rather than first retracting the stopper 337 , the clinician may simply twist the handle to advance the pusher relative to the stopper 337. Soon toe stopper 337 will become unthreaded from toe coupling member 374 and will slide freely over toe central shaft section 372, allowing the clinician to quickly and easily advance the pusher member 330.

In toe embodiments just discussed, toe delivery tube segments 350f, 350g are configured to separate when the pusher member 330 is advanced. In some embodiments, toe delivery tube segments may completely separate, while in other embodiments, only portions of the delivery tube 350 may separate. Preferably, at least toe distal portions of toe tube separate. The segments preferably are configured such that advancement of toe pusher member 330 engages toe delivery tube 350 so that material within the tube can be dispatched therefrom.

With reference to Figures 40, 41 and 42a-b, a vascular wound closure assembly 430 includes an elongate catheter 432 having a distal end 434 and a proximal end 436. A distal opening 438 is formed through the distal end 434 of the catheter 432 and opens along a longitudinal axis of toe catheter 432. The catheter 432 includes a tapered tip 4440 at toe distal end 434. An elongate main body 42 of the catheter 432 is disposed proximal the tapered tip 4440, Preferably the main body 42 has a substantially uniform diameter along its length. A lumen 444 extends longitudinally within toe catheter 432 from toe distal opening 438 to the proximal end 436.

A connector portion 446 is provided on toe proximal end 436. The connector portion 446 includes a main lumen 448 and a secondary lumen 450. The main lumen 448 extends along toe longitudinal axis of toe catheter 432 and is coextensive with the catheter lumen 444. The secondary lumen 450 extends outwardly from the main lumen 448, but communicates with the main lumen 448 and the catheter lumen 444. A proximal opening 452 is provided at toe proximal end of toe main lumen 448 and, like toe distal opening 438, opens along the longitudinal axis. A secondary opening 454 opens into the secondary lumen 450.

-34CA 02801969 2013-01-10

The distal and proximal openings 438,452 are sized and adapted to accommodate a guidewire 458 such as the guidewire used in angioplasty and other vascular surgeries. As such, the guidewire 458 can be threaded through the catheter 432 and the catheter can be advanced over the guidewire 458.

A hole 460 is formed through a side-wall of the catheter 432 near the distal end of the catheter. In another embodiment, at least two holes are provided, All of the holes preferably are disposed substantially the same distance from the distal end of the catheter.

With continued reference to Figures 40,41 and 42a-b, a vacuum or other source of suction 464 is provided and communicates, through tubing 466, with the secondary lumen 450 of the catheter connector portion 446. Thus, a vacuum is drawn through the catheter lumen 44. Preferably, the distal and proximal openings 438, 452, which accommodate the guidewire 458, are sized so that the guidewire 458 substantially plugs the openings; thus, the vacuum is drawn through the hole 460. A viewing port 468 is arranged between the source of suction 464 and the catheter 432. The viewing port 468 is configured to allow a clinician to view the material that is drawn by suction through the hole and through the catheter lumen 44.

A delivery tube 490 is disposed over the catheter 432 proximal of the hole 460. A pusher member- 500 also is disposed over the catheter 432 generally proximal of the delivery tube 490. The delivery tube 490 and pusher member 500 will be discussed in more detail below. The delivery tube 490 and pusher member 500 preferably are selectively secured to the catheter 432 so that they are in a fixed position relative to the catheter. More specifically, the delivery tube 490 preferably is releasably secured to the catheter 432 so that a distal end 502 of the delivery tube 490 is spaced a distance between about 0.5 to 1.5 cm proximal of the hole 460. More preferably, the distal end 502 of the delivery tube 490 is spaced less than about 1 cm from the hole.

With reference also to Figure 43, the illustrated vascular wound closure assembly 430 can be precisely positioned adjacent a subcutaneous vascular wound “w” in order to close the wound. With reference to Figures 40-43 and 50, in order to precisely locate and provide access to a femoral artery puncture wound w, the catheter 432 is first threaded over the guidewire 458, which has been previously inserted into the patient's femoral artery 94 through the puncture wound w. The lumen 444 is attached to the source of suction 464 and

-35CA 02801969 2013-01-10 the assembly 430 is advanced over the guidewire 458 through a patient's tissue 96 so that the distal tip 440 of the catheter 432 extends through the vascular puncture wound w.

As the assembly 430 is advanced, the source of suction 464 draws bodily fluids through the hole 460. The fluids pass through the viewing port 468, which allows the clinician to identify the fluids being withdrawn. The viewing port 468 can have any suitable structure or location. For example, the viewing port can comprise clear tubing attached to the catheter, a substantially transparent syringe that functions as both a source of suction and a viewing port, or a portion of the catheter that is substantially transparent. Most preferably, the catheter 432 is formed of a transparent material so that the clinician becomes aware as soon as blood begins to be drawn through the catheter.

When the hole 460 passes the artery wall 98 and enters the blood vessel 94, as shown in Figure 43, blood b begins to be drawn through the hole 460 into the catheter 432 and is conducted past the viewing port 468. Tirus, when blood b is observed in the viewing port 468, the clinician will know that the hole 460 has just passed into the puncture wound w and that the distal end 502 of the delivery tube 490 thus positioned adjacent the outer wall 98 of the artery 94, preferably within about 1 cm of tire artery wall 98.

With reference next to Figure 44, the delivery tube 490 is generally elongate and comprises first and second separately-formed members 492, 494that engage one another to form the dehvery tube 490. Each tube member 492, 494 has a distal end 502, a proximal end 504, an outer surface 506 and an inner surface 508. Guide posts 510 formed on one of the tube members 492, 494 fit into guide recesses 512 formed in the other member so as to align the tube members 492, 494. When connected and aligned as shown in Figure 4, the tube members 492, 494 form the delivery tube 490. As shown, the proximal end 504 of the delivery tube 490 preferably is threaded on its outer surface 506. A handle portion 514 is disposed distal of the proximal end 504, and the delivery tube 490 generally tapers from the handle 514 to the distal end 502.

A chamber 520 is formed within the delivery tube 490, and the catheter 432 extends therethrough. At the distal end 502 of the delivery tube 490, the chamber 520 is just large enough to accommodate the catheter 432. However, as the tube tapers in a proximal direction, a space 522 is defined between the catheter 432 and the inner surface 508 of tide tube 490. In the illustrated embodiment, the space 522 is packed with a therapeutic agent, preferably a hemostatic material 270 that can be delivered from the tube 490

-36CA 02801969 2013-01-10 subcutaneously and adjacent the vascular wound w. A distal end 528 of the pusher member

500 is accommodated within the proximal end 504 of the delivery tube 490.

In a preferred embodiment, the hemostatic material 270 comprises a hydrophilic fibrous fleece. Throughout this description, the term fleece is used as a broad term in its ordinary sense and refers to, without limitation, in a non-woven or a woven cloth form or in a puff or ball form. It is to be understood that the fibrous fleece may be treated or coated in any suitable manner to enhance its hydrophilic properties and/or its hemostatic properties, In a preferred embodiment, fibrous chitosan fleece is treated to deposit a hemostatic agent thereon. Most preferably, microporous polysaccharide microspheres are deposited on the fleece.

With reference next to Figure 45, the pusher member 500 comprises an elongate body 530 and has distal and proximal ends 528, 532. A lumen 534 is formed longitudinally through tire pusher member 500, and preferably is sized to slidably accommodate the catheter 432 therethrough. Preferably, the pusher member 500 is rigid enough so that it can be grasped at or near its proximal end 532 and pushed forward, in turn engaging and pushing the hemostatic material 270 within the delivery tube 490, without binding or bending excessively. The distal portion 528 of the pusher member 500 is configured to fit within a proximal portion 504 of the delivery tube 490. However, the distal portion 528 of foe pusher member 500 preferably has a greater diameter than at least a portion of the delivery tube 490 near the distal end 502 of the delivery tube 490. As such, when the pusher member 500 is advanced relative to the delivery tube 490, the pusher member 500 engages the inner surface 508 of the tube members 492,494 and forces them apart so as to deploy the hemostatic material 270 from within the delivery tube 490.

In the illustrated embodiment, the pusher member 500 is threaded along its proximal end 532. An annular ridge 540 is formed a distance “d” from the distal end 528 of the pusher member 500. The annular ridge 540 projects radially, outwardly a very small distance from an outer surface of the pusher member 500. Since the annular ridge 540 projects only a very small distance from the surface of the pusher member 500, it does not interfere with the pusher member’s slidability into the proximal end 504 of the delivery tube 490.

hi the illustrated embodiment, the pusher member 500 has a diameter of about 4 mm and a lumen diameter 534 of about 2 ram. The annular ring 540 extends outwardly

-37CA 02801969 2013-01-10 from the outer surface a distance of between about 0.1 mm to 0.25 mm, and, more preferably, about 0.15 mm.

With reference also to Figure 46, which shows a close up view of the distal portion 528 of the pusher member 500 as installed on the delivery tube 490, preferably a pair of elastomeric annular locking members 544 are disposed around the pusher member 500. The locking members 544 preferably are arranged immediately adjacent either side of the annular ridge 540, and are sized so as to engage the proximal end 504 of the delivery tube 490 so as not to slide into or over the delivery tube 490. Preferably, the elastomeric locking members 544 are fit about the pusher members 500 so that they can be slid along the pusher member 500, and even can slide over the annular ridge 540.

An internally threaded locking cap 546 is configured to be threaded onto the proximal end 504 of the delivery tube 490. The locking cap 546 has proximal wall 548 having a hole 549 formed therethrough. The hole 549 is sized to accommodate and slide over the pusher member body 530. As shown, the locking members 544 are arranged on the pusher member body 530 adjacent either side of the annular ridge 544, and the pusher member 500 is inserted into the delivery tube 490 until the locking members 544 engage the proximal end 504 of the delivery tube 490. The cap 546 is then advanced over the pusher member 500 and threaded into place on the delivery tube 490. As the cap 546 is tightened, the proximal wall 548 of the cap 546 engages the locking members 544, which are then compressed longitudinally between the cap proximal wall 548 and delivery tube proximal end 504. Due to their elastomeric properties, as the locking members 544 are compressed longitudinally, they expand laterally, and thus tightly engage the pusher member 500 at and adjacent the annular ridge 544.

In the illustrated embodiment, the locking members 544 tightly engage the annual ridge 540 such that they resist sliding over the ridge. Since a locking member 544 is disposed on each side of the ridge 540, the pusher 500 is thus prevented from sliding in either a proximal or a distal direction, relative to the tube 490. However, once the cap 546 is loosened and the locking members 544 are released from compression, the annular ridge 540 is slidable through the locking members 544, and the pusher 500 is correspondingly slidable,

-38CA 02801969 2013-01-10

In the illustrated embodiment, the locking cap 546 and delivery tube 490 are threaded. It is to be understood that any other fastening mechanism may be employed, such as for example a J-lock or detent.

The illustrated embodiment employs an annulai- ridge 540 disposed on the pusher 5 member 500. It is to be understood, however, that other configurations employing a similar principle can be acceptable. For example, any type of protuberance, including a bump, a series of bumps, spikes or any other protuberance that projects from a surface of the pusher member 500 can be employed. Further, protuberances can be employed at only one area disposed a predictable distance from the distal end of the pusher member as shown in the illustrated embodiment, or, in other embodiments, can be disposed at various locations or even continuously along the pusher member so as to allow customization and optimization of the placement and locking position of the pusher member relative to the delivery tube. Further, in other embodiments, rather than a series of humps or the like, the pusher member surface can be treated to create a surface roughness, such as by being sanded with a low grit sandpaper, or to be pitted. In such an instance, protuberances are considered to extend from the lowest portions of the pits, grooves or the like. When the locking members 544 are longitudinally compressed, the locking members will expand transversely and tightly engage at least portions of the pits and protuberances so as to fix the pusher member 500 in position relative to the delivery tube 490, As such, a protuberance is considered to be any surface aspect upon which a locking member may obtain purchase to grip the pusher . member when the cap is tightened.

In the illustrated embodiment, the locking members 544 comprise elastomeric rings. It is to be understood that, in other embodiments, the locking members may be shaped differently, and may extend around only a portion of the pusher member. Further, although the illustrated embodiment shows two locking members 544 disposed one on either side of the annular ridge 540, it is to be understood that other embodiments may employ only a single locking member, or more than two locking members, configured to releasably engage an annular ridge or other protuberance configuration. In still another embodiment, one or more locking members are employed, but no protuberances are formed on the pusher member surface, hi this embodiment, the locking members are pushed tightly against the pusher member when the cap is tightened so as to increase the friction between the locking

-39CA 02801969 2013-01-10 members and the pusher member, and accordingly resist movement of the pusher member relative to the delivery tube.

With reference next to Figure 47, the catheter 432 preferably comprises a stop member 550 extending radially outwardly from the catheter surface. In tire illustrated embodiment, the stop member 550 comprises an annular ring; however, it is anticipated that any sort of protuberance can be employed. With reference also to Figure 48, a coupling member 552 preferably is movably disposed about the catheter 432 and is configured to mechanically couple to the proximal end 532 of the pusher member 500. In the illustrated embodiment, the coupling member 552 is threaded on its inner surface in order to engage the threaded proximal end 532 of the pusher member 500. When the coupling member 552 and pusher member 500 are engaged, the catheter stop member 550 is locked between the proximal end 532 of the pusher member 500 and a proximal wall 554 of the coupling member 552. As such, the catheter 432 is selectively fixed in position relative to the pusher member 500. As discussed above, the pusher member 500 is selectively fixed in position relative to the delivery tube 490. As such, when the locking cap 546 and coupling member 552 are engaged as discussed above, the catheter 432, pusher member 500 and delivery tube 490 are all in fixed positions relative to one another.

In another embodiment, the catheter 432 comprises a protuberance, such as an annular ring, and one or more locking members are provided so as to releasably secure the pusher member 500 to the catheter 432 when the coupling member 552 is engaged.

With reference next to Figure 49, a collar 560 is illustrated. The illustrated collar 560 preferably is made of a polymer formed as a broken ring. As such, the collar 560 is resilient and circumferentially expandable.

With reference also to Figures 40-43, 50 and 51, the collar 560 preferably is configured to fit about the delivery tube 590. A relaxed diameter of the collar 560 is less than the diameter of at least most of the tapered portion of the delivery tube 490. Thus, the collar 560 is circumferentially expanded in order to fit over the delivery tube 490. Such circumferential expansion is resisted by the collar 560 so that the collar 560 exerts an inwardly-directed force on the delivery tube 490. In order to ease advancing of the tube through tissues, the outer diameter of the delivery tube 490 is made quite small. As a result, the width of the walls of the tube members 492, 494 preferably is quite small. In some embodiments, the thin-walled tube members are somewhat flexible. The inwardly-40CA 02801969 2013-01-10 directed force exerted by the collar 560 helps hold the tube members 492, 494 together so as to fit closely about the catheter 432 and to contain the hemostatic material 270 within the chamber 522.

hi the illustrated embodiment, the collar 560 is configured to be slidable over the delivery tube 490. Preferably both the collar 560 and delivery tube 490 have smooth engaging surfaces. It is to be understood that other surface configurations can be used as appropriate. With reference next to Figures 43,50 and 51, to correctly position the vessel closure device 430, the assembly is advanced over a guidewire 458 into position adjacent the wound w. Figure 50 shows the assembly 430 partially advanced through body tissues 96 toward a puncture wound w. As the apparatus 430 is advanced, the collar 560 engages the patient’s skin, as shown in Figure 50. As the apparatus is further advanced, the collar 560 continues to engage the patient’s skin and the delivery tube 490 slides distally relative to the collar 560, as shown in Figure 43. The collar expands with the diameter of the tapered delivery tube 490 as the tube slides relative to the collar 560, and the collar continues to exert a circumferential force to help hold the tube closed. It is anticipated that the body tissue 96 surrounding the portion of the delivery tube 490 distal of the collar 560 also helps to keep the tube closed.

When the apparatus 430 is in a desired position at or adjacent a wound w, as shown in Figure 43, the coupling member 552 and cap 546 are disengaged so that the pusher member 500 can be advanced relative to the delivery tube 490 and catheter 432. With particular· reference to Figure 51, as the pusher member 500 is advanced, tire distal end 528 of the pusher member 500 engages inner surfaces 508 of the tube members 492, 494, thus forcing the tube members 492, 494 apart and deploying the hemostatic material 270 from within the delivery tube chamber 522. In the embodiment illustrated in Figure 51, the tube members 492, 494 are flexible so that they will bend outwardly upon urging from the advancing pusher member 500.

As discussed above, in one embodiment, the hemostatic material 270 comprises a hydrophilic fibrous chitosan fleece. Since the fleece is hydrophilic, it sticks to the blood vessel 98 surrounding the wound and to surrounding body tissues 96. Further, since the fleece 270 is fibrous, and since the catheter 432 effectively plugs the wound w as the material is deployed, none of the fibrous material passes through the wound into the blood vessel 94. Further, as the catheter 432 is removed from the wound w, the fleece readily

-41CA 02801969 2013-01-10 collapses into the space previously taken by the catheter. The fleece has hemostatic properties, and. folly surrounds the wound w, thus aiding relatively quick hemostasis of the wound.

hi some embodiments the closure device 430 is assembled so that the distance from the catheter hole 460 to the distal end 502 of the delivery tube 490 is about or slightly greater than the width of a blood vessel wall 98. As such, the delivery tube 490 is arranged immediately adjacent the wound w. With continued reference to Figures 43 and 51, in the illustrated embodiment, the distance from the catheter holes 460 to the distal end 502 of the delivery tube 490 is much greater than the width of a blood vessel wall 98, but less than about 1.5 cm. More preferably the distance is about 1 cm or less. As such, when the catheter holes 460 enter the blood vessel 94 and the clinician sees blood enter the viewing port 468, the delivery tube 490 is positioned close to but spaced from the vessel wall 98. In the illustrated embodiment, this is a safety feature to ensure than the distal ends 502 of the delivery tube members 492, 494 do not enter or damage the wound site w. Upon . deployment of the hemostatic material 270, the pusher member 500 pushes the material over the catheter 432 and into contact with, or into close proximity to, the vessel wall 98 and the wound w. In accordance with, another embodiment, the delivery tube 490 is spaced from the vessel wall 98 a distance of at least about three times the thickness of the vessel wall.

With continued reference to Figure 51, when the tube members 492, 494 are expanded upon deployment as illustrated, there is further resistance to distal movement of the tube members 492, 494, thus further contributing to safety. Still further, although the collar 560 is slidable over the delivery tube 490, it contributes some frictional resistance so further distal movement of the delivery tube 490 relative to the collai· 560.

The most common sizes of catheters used for interventions through the femoral artery are sized about 6F or less, hi the embodiment illustrated in Figures 40-51, the catheter 432 preferably is about 6.5F in size. Since the catheter 432 of the closure device is of greater diameter than the catheters used by the clinician prior to closure of the wound, the catheter 432 is large enough to tightly engage the wound edges and effectively plug the wound. This tight fit of the catheter 432 relative to the wound w helps prevent hemostatic material 270 from passing between the catheter and the wound edges and into the blood vessel 94. It is to be understood that different sizes of catheters may be used for

-42CA 02801969 2013-01-10 interventions, and for the closure apparatus. Preferably the closure apparatus catheter 432 has a greater diameter than catheter(s) and other surgical implements used in the procedure prior to closure. Preferably, the catheter 432 has a diameter about 0-1F, and more preferably about Û.5F, greater than earlier-used catheters.

in accordance with still another embodiment, the delivery tube 490 comprises indicia printed or otherwise marked thereon, hi use, the clinician notes, during initial vascular puncture, the depth of the puncture. Later, during vessel closure, the indicia on the delivery tube 490 serves as a reference for the clinician to verify the depth of the tube and its position relative to the vascular wound. It is to be understood that such indicia may be printed on the delivery tube or may be physically fonned as raised or lowered portions of the tube.

In accordance with another embodiment, a vascular wound closure apparatus having features as discussed above in connection with Figures 12-23, 25-28, 29-37, or 40-51 is provided in a kit for use by a clinician hi this embodiment, the apparatus is formed of a disposable, yet suitable material, such as a medical grade plastic, and is assembled and loaded so that the members are releasably coupled to one another and hemostatic material is disposed in the delivery tube. Although the apparatus may be provided pre-assembled, a clinician may still adjust the position of the tube relative to the catheter by decoupling the tube and pusher member, making the adjustment, and then recoupling the tube and pusher member. The apparatus is sterilized and preferably is disposed within a closed, sterilized container (not shown) which is configured to be opened in a sterile environment such as an operating room or catheter lab.

Although tlris invention has been disclosed in the context of certain preferred embodiments and examples, it will be understood by those skilled in the art that the present invention extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses of the invention and obvious modifications and equivalents thereof. In addition, while a number of variations of the invention have been shown and described in detail, other modifications, which are within the scope of this invention, will be readily apparent to those of skill in the art based upon tins disclosure, It is also contemplated that various combinations or subcombinations of the specific features and aspects of the embodiments may be made and still fall within the scope of the invention. Accordingly, it should be understood that various features and aspects of the disclosed

-43CA 02801969 2013-01-10 embodiments can be combined with or substituted for one another in order to fonn varying modes of tire disclosed invention. Thus, it is intended that the scope of the present invention herein disclosed should not be limited by the particular disclosed embodiments described above, but should he determined only by a fair reading of the claims that follow.